{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:29:35Z","timestamp":1791415775235,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004562","name":"ministry of higher education and research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.neuropharm.2017.08.039","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T03:46:01Z","timestamp":1504583161000},"page":"142-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation"],"prefix":"10.1016","volume":"126","author":[{"given":"Flavien","family":"Bessaguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Danigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Magy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-5162","authenticated-orcid":false,"given":"Franck","family":"Sturtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Desmouli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6199-4534","authenticated-orcid":false,"given":"Claire","family":"Demiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.08.039_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/jpet.114.216382","article-title":"Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in\u00a0vivo through modulation of tumor angiogenesis","volume":"350","author":"Alhusban","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther. Sept."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3940(95)12287-7","article-title":"Stimulation by nerve growth factor of neuropeptide synthesis in the adult rat in\u00a0vivo: bilateral response to unilateral intraplantar injections","volume":"203","author":"Amann","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12990-015-0038-x","article-title":"Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in\u00a0vitro studies","volume":"11","author":"Anand","year":"2015","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ddr.21280","article-title":"Fosinopril prevents the development of tactile allodynia in a streptozotocin-induced diabetic rat model","volume":"76","author":"Araiza-Salda\u00f1a","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mus.23910","article-title":"Small fibers, large impact: quality of life in small-fiber neuropathy","volume":"49","author":"Bakkers","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.HYP.0000241061.51003.b7","article-title":"Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade","volume":"48","author":"Barker","year":"2006","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2008.06.079","article-title":"Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice","volume":"442","author":"Beiswenger","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/14737175.2016.1150179","article-title":"The therapeutic potential of renin angiotensin aldosterone system (RAAS) in chronic pain: from preclinical studies to clinical trials","volume":"16","author":"Bessaguet","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib9","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1007\/s12035-015-9584-5","article-title":"Angiotensin receptor blockade modulates NF\u03baB and STAT3 signaling and inhibits glial activation and neuroinflammation better than angiotensin-converting enzyme inhibition","volume":"53","author":"Bhat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Sci. (80-. )"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/diabetes.55.02.06.db05-0885","article-title":"ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats","volume":"55","author":"Coppey","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2014.04.026","article-title":"A\u00a0reversible functional sensory neuropathy model","volume":"571C","author":"Danigo","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12933-015-0185-4","article-title":"Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice","volume":"14","author":"Danigo","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib14","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1167\/iovs.12-10826","article-title":"Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment","volume":"53","author":"Davidson","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-328X(98)00079-5","article-title":"Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves","volume":"57","author":"Gallinat","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2006.05.029","article-title":"Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress","volume":"51","author":"Hamai","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/db11-1468","article-title":"Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats","volume":"61","author":"Hashikawa-Hobara","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2004.11.053","article-title":"Decreased sensory neuropeptide release in isolated bronchi of rats with cisplatin-induced neuropathy","volume":"507","author":"Horvath","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/nen.0b013e3181630bb8","article-title":"Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy","volume":"67","author":"Hsieh","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib20","first-page":"12","article-title":"A\u00a0review on Candesartan: pharmacological and pharmaceutical profile","volume":"1","author":"Husain","year":"2011","journal-title":"J.\u00a0Appl. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1054\/JCPT.2000.19245","article-title":"Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKC proteins and cGMP","volume":"5","author":"Jugdutt","year":"2000","journal-title":"J.\u00a0Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0306-4522(95)00334-F","article-title":"Coexpression of preprotachykinin-A, alpha-calcitonin gene-related peptide, somatostatin, and neurotrophin receptor family messenger RNAs in rat dorsal root ganglion neurons","volume":"70","author":"Kashiba","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1470320314556171","article-title":"Ameliorative potential of angiotensin-converting enzyme inhibitor (ramipril) on chronic constriction injury of sciatic nerve induced neuropathic pain in mice","volume":"16","author":"Kaur","year":"2015","journal-title":"J.\u00a0Renin. Angiotensin. Aldosterone. Syst."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib24","first-page":"4413","article-title":"Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy","volume":"31","author":"Koskinen","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","article-title":"EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy","volume":"12","author":"Lauria","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib26","first-page":"875","article-title":"Skin innervation: important roles during normal and pathological cutaneous repair","volume":"30","author":"Laverdet","year":"2015","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0306-4522(89)90310-2","article-title":"Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor","volume":"33","author":"Lindsay","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.188.4.661","article-title":"The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats","volume":"188","author":"Lucius","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0140-6736(98)02478-7","article-title":"Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial","volume":"352","author":"Malik","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/dmrr.401","article-title":"Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor","volume":"19","author":"Manschot","year":"2003","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cell.2014.04.040","article-title":"Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways","volume":"157","author":"Marion","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib32","doi-asserted-by":"crossref","first-page":"50080","DOI":"10.1074\/jbc.M306619200","article-title":"Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway","volume":"278","author":"Mohapatra","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/pme.12258","article-title":"Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain","volume":"15","author":"Muralidharan","year":"2014","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1744-8069-9-38","article-title":"Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice","volume":"9","author":"Nemoto","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.clinph.2013.09.038","article-title":"Sensory correlates of pain in peripheral neuropathies","volume":"125","author":"Ng Wing Tin","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/oby.2007.19","article-title":"Attenuation of vascular\/neural dysfunction in zucker rats treated with enalapril or rosuvastatin","volume":"16","author":"Oltman","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1586\/ern.09.88","article-title":"Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?","volume":"9","author":"Oprisiu-Fournier","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.regpep.2010.03.004","article-title":"Intraneuronal angiotensinergic system in rat and human dorsal root ganglia","volume":"162","author":"Patil","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10571-013-9934-7","article-title":"Effect of subpressor dose of angiotensin II on pain-related behavior in relation with neuronal injury and activation of satellite glial cells in the rat dorsal root ganglia","volume":"33","author":"Pavel","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2008.09.099","article-title":"Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat","volume":"1246","author":"Pavel","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib41","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1096\/fj.02-1193fje","article-title":"Angiotensin II accelerates functional recovery in the rat sciatic nerve in\u00a0vivo: role of the AT2 receptor and the transcription factor NF-kappaB","volume":"17","author":"Reinecke","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-8993(86)90835-8","article-title":"Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii","volume":"364","author":"Rettig","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib43","first-page":"169","article-title":"Effects of captopril and losartan on thermal and chemical induced pain in mice","volume":"50","author":"Rohit","year":"2006","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib44","doi-asserted-by":"crossref","first-page":"19462","DOI":"10.1074\/jbc.M111.289751","article-title":"Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation","volume":"287","author":"Sanz-Salvador","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/pme.12063","article-title":"Small molecule angiotensin II type 2 receptor (at 2 R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats","volume":"14","author":"Smith","year":"2013","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib46","first-page":"1512457","article-title":"Integrating TRPV1 receptor function with capsaicin psychophysics","volume":"2016","author":"Smutzer","year":"2016","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib47","first-page":"331","article-title":"Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice","volume":"59","author":"Takail","year":"1996","journal-title":"Life Sci. Cqyight"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1463-1326.2011.01499.x","article-title":"Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats","volume":"14","author":"Takata","year":"2012","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.neuropharm.2017.08.039_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/138945008783431736","article-title":"The potential role of angiotensin converting enzyme and vasopeptidase inhibitors in the treatment of diabetic neuropathy","volume":"9","author":"Yorek","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2017.08.039_bib51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/00207454.2014.948115","article-title":"Investigation of the effect of telmisartan on experimentally induced peripheral nerve injury in rats","volume":"125","author":"Yuksel","year":"2015","journal-title":"Int. J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T11:11:54Z","timestamp":1617621114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817304173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":50,"alternative-id":["S0028390817304173"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.039","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}